'Ckd mbd' presentation slideshows

Implementing an Evidence-Based Stage-Specific Clinical Action Plan

Implementing an Evidence-Based Stage-Specific Clinical Action Plan. Jeffrey S. Berns, MD. Steps to CKD Patient Care. Does the patient have CKD? Assess GFR, albuminuria Determine etiology Assess for evidence of progression Assess for associated complications Patient education

691 views • 55 slides

Shofa chasani

CHRONIC KIDNEY DISEASE (CKD). Shofa chasani. Objectives To understand the basic informations on etiology,staging,diagnosis and treatment. To know complications of CKD and their treatment . To analyze the mechanism and pathophysiology of CKD progression and therapies to slow progression.

488 views • 48 slides

Linda McCann, RD, CSR,LD Senior Director of Quality Satellite Healthcare, Inc. Mountain View, CA

758 views • 46 slides

Dr Akram Askar MRCP, SSC (Nephro)

CHRONIC KIDNEY DISEASE (CKD). Dr Akram Askar MRCP, SSC (Nephro). Objectives To understand the basic informations on etiology,staging,diagnosis and treatment. To know complications of CKD and their treatment .

458 views • 44 slides

597 views • 42 slides

CKD

505 views • 41 slides

Calcium & phosphor disturbance CKD- MBD

Calcium & phosphor disturbance CKD- MBD. Dr. Atapour. Phosphor. P arathyroid hormone (PTH) 1,25(OH)2D ( calcitriol ) P hosphatonins , (fibroblast growth factor 23 (FGF23) T arget organs: Bone Kidney Intestine. GFR levels below 60 mL /min GFR below 30 mL /min.

717 views • 34 slides

Improving Management of Secondary Hyperparathyroidism (SHPT) in Non-Dialysis Patients

Improving Management of Secondary Hyperparathyroidism (SHPT) in Non-Dialysis Patients. CKD Is a Global Burden With Major Implications. CKD-MBD. Pathophysiology of CKD-MBD. Biochemical Phenotype of Disordered Mineral Metabolism in CKD. SHPT Is a Component of CKD-MBD Pathophysiology.

995 views • 30 slides

Spain Fosrenol Market Education Programme

244 views • 1 slides